Literature DB >> 18691786

Association of WBC count and glucose metabolism among Chinese population aged 40 years and over.

Jing-Yan Tian1, Yan Yang, Qi Cheng, Hong-Er Huang, Rui Li, Guo-Xin Jiang, Shi-You Liu, Xiao-Ying Li, Guang Ning.   

Abstract

Chronic subclinical inflammation may be involved in the pathogenesis of Type 2 diabetes. We examined whether elevated WBC count, a marker of inflammation, was associated with worsening of glucose tolerance among Chinese population aged 40 years and over. Based on the 75g OGTT, 1016 subjects aged from 40 to 88 years were classified into four groups: NFG/NGT (n=299), isolated IFG (n=213), IGT (n=213) and Type 2 diabetes (n=291). We compared the WBC count among the four groups and investigated relevant variables associated significantly with the WBC count. The IGT and Type 2 diabetes groups had a significantly higher WBC count than the NFG/NGT and isolated IFG groups. By stepwise regression analyses, we found that waist circumference, DBP, total cholesterol, HDL cholesterol and 2-h PG showed an independent association with the WBC count. In the analysis stratified by sex and smoking status, WBC count was independently associated with age and triglycerides in males, whereas it was associated with BMI, SBP, triglycerides and 2-h PG in females. BMI, SBP, triglycerides and 2-h PG showed an independent association with WBC count in subjects who never smoked. We concluded that an increase in WBC count was associated with the deterioration of glucose tolerance. WBC count was associated with lipid metabolism in males and with various components of the metabolic syndrome in females and subjects who never smoked.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18691786     DOI: 10.1016/j.diabres.2008.05.014

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  6 in total

1.  Relationships between C-reactive protein, white blood cell count, and insulin resistance in a Chinese population.

Authors:  Yu Xu; Zhiyun Zhao; Xiaoying Li; Yufang Bi; Min Xu; Guang Ning
Journal:  Endocrine       Date:  2010-11-15       Impact factor: 3.633

2.  Waist circumference-dependent peripheral monocytes change after gliclazide treatment for Chinese type 2 diabetic patients.

Authors:  Qing Li; Hao-Yong Yu; Miao Chen; Feng Jiang; Jian Zhou; Yu-Qian Bao; Cheng Hu; Wei-Ping Jia
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-04-11

Review 3.  Differential white blood cell count and type 2 diabetes: systematic review and meta-analysis of cross-sectional and prospective studies.

Authors:  Effrossyni Gkrania-Klotsas; Zheng Ye; Andrew J Cooper; Stephen J Sharp; Robert Luben; Mary L Biggs; Liang-Kung Chen; Kuppan Gokulakrishnan; Markolf Hanefeld; Erik Ingelsson; Wen-An Lai; Shih-Yi Lin; Lars Lind; Vitool Lohsoonthorn; Viswanathan Mohan; Antonio Muscari; Goran Nilsson; John Ohrvik; Jiang Chao Qiang; Nancy Swords Jenny; Koji Tamakoshi; Theodora Temelkova-Kurktschiev; Ya-Yu Wang; Chittaranjan Sakerlal Yajnik; Marco Zoli; Kay-Tee Khaw; Nita G Forouhi; Nicholas J Wareham; Claudia Langenberg
Journal:  PLoS One       Date:  2010-10-18       Impact factor: 3.240

4.  Elevated white blood cell count is associated with higher risk of glucose metabolism disorders in middle-aged and elderly Chinese people.

Authors:  Hua Jiang; Wen-Hua Yan; Chan-Juan Li; An-Ping Wang; Jing-Tao Dou; Yi-Ming Mu
Journal:  Int J Environ Res Public Health       Date:  2014-05-20       Impact factor: 3.390

5.  A Higher Serum Anion Gap Is Associated with the Risk of Progressing to Impaired Fasting Glucose and Diabetes.

Authors:  Yingchao Zhang; Fengran Xiong; Ruxuan Zhao; Tingting Shi; Jing Lu; Jinkui Yang
Journal:  Int J Endocrinol       Date:  2021-12-13       Impact factor: 3.257

6.  Insulin Resistance in Relation to Lipids and Inflammation in Type-2 Diabetic Patients and Non-Diabetic People.

Authors:  Ying-Mei Feng; Dong Zhao; Ning Zhang; Cai-Guo Yu; Qiang Zhang; Lutgarde Thijs; Jan A Staessen
Journal:  PLoS One       Date:  2016-04-13       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.